447 filings
Page 10 of 23
6-K
7qsem gf3
19 Mar 20
Current report (foreign)
10:47am
6-K
tmie4ilw20z7jbko86
19 Mar 20
Current report (foreign)
10:45am
6-K
cr1j57zdg2pz ce1ql
17 Mar 20
Current report (foreign)
1:46pm
6-K
ir2 vafboqlgndqqu
16 Mar 20
Current report (foreign)
8:14am
6-K
6dg0nh ezc
13 Mar 20
Current report (foreign)
9:35am
6-K
sipsw79g26y3ya7
12 Mar 20
Current report (foreign)
5:30pm
6-K
4l4f3kzoa84phhsx
12 Mar 20
Current report (foreign)
5:02pm
SC 13D/A
1tu253ver1njkzohy
12 Mar 20
Biofrontera / DEUTSCHE BALATON AKTIENGESELLSCHAFT ownership change
4:05pm
6-K
upyc1i3wikvtvu
12 Mar 20
Current report (foreign)
12:00am
6-K
i0629ein0ha6
10 Mar 20
European Commission approves use of AmeluzĀ® for the treatment of actinic keratosis on extremities and trunk/neck
1:31pm
6-K
12ydh ngiw
9 Mar 20
1. Details of the person discharging managerial responsibilities / person closely associated
2:07pm
6-K
09j3 hfz65e6f3z
9 Mar 20
1. Details of the person discharging managerial responsibilities / person closely associated
2:04pm
6-K
esiqi
9 Mar 20
1. Details of the person discharging managerial responsibilities / person closely associated
2:02pm
6-K
x2bq3xd6s
9 Mar 20
1. Details of the person discharging managerial responsibilities / person closely associated
1:58pm
6-K
nbx7 3lyzy
9 Mar 20
1. Details of the person discharging managerial responsibilities / person closely associated
1:49pm
6-K
32tzpiha6ugdyvmzk
9 Mar 20
1. Details of the person discharging managerial responsibilities / person closely associated
1:47pm
6-K
dgc uioiq3d0
6 Mar 20
1. Details of the person discharging managerial responsibilities / person closely associated
6:15am
6-K
xcdkgjneymdoy xia8t1
6 Mar 20
1. Details of the person discharging managerial responsibilities / person closely associated
6:15am
6-K
6tcbslk wt
6 Mar 20
1. Details of the person discharging managerial responsibilities / person closely associated
6:15am
6-K
ncy5t7
5 Mar 20
Current report (foreign)
8:03am